Trellus Health (TRLS)

Sector:

Health Care

Index:

FTSE AIM All-Share

2.13p
   
  • Change Today:
    -0.13p
  • 52 Week High: 9.20p
  • 52 Week Low: 2.13p
  • Currency: UK Pounds
  • Shares Issued: 161.51m
  • Volume: 0
  • Market Cap: £3.43m

Deal with Barclays    Trade now with Barclays Stockbrokers

Trellus Health signs two contracts with Mount Sinai

By Josh White

Date: Monday 17 Oct 2022

LONDON (ShareCast) - (Sharecast News) - Healthcare self-management technology company Trellus Health has signed two contracts with the Mount Sinai Health System, it announced on Monday, to provide access to its resilience training and self-management programme for inflammatory bowel disease.
The AIM-traded firm said the first contract would see Mount Sinai make the Trellus IBD programme available to, and paid for, as a wellness benefit to all employees, focusing initially on inflammatory bowel disease (IBD), including Crohn's disease, and ulcerative colitis.

It said Mount Sinai had a "robust" employee wellness program offered free-of-charge to all faculty and staff.

The second contract would make the Trellus IBD program available to eligible patients, again as a wellness benefit, who are members of a large New York state labour union which provides health services and benefits to its members through Mount Sinai.

Trellis said the contracts supported its strategy of accessing patients to expand the rollout of its solution.

"As announced in our recent half-year report, Trellus has been making significant progress in advancing our business-to-business-to-consumer strategy, and I am delighted that we have signed these contracts with such a prestigious partner as Mount Sinai," said chief executive officer Dr Marla Dubinsky.

"We believe that these contracts reflect the importance of our solution to healthcare providers and employers who want to empower their patients and employees to master the art of self-management, manage their chronic conditions with confidence, and improve health outcomes at a significantly lower cost."

Dr Dubinsky said Trellus represented "a paradigm shift" in the way patients with chronic health conditions were supported, incorporating a whole-person methodology that to-date had been "missing" from the "collective" approach.

"These contracts with Mount Sinai will support our commercial goals of adding more patient members to the Trellus programmes through increased access."

At 1118 BST, shares in Trellus Health were up 5.56% at 14.25p.

Reporting by Josh White at Sharecast.com.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Trellus Health Market Data

Currency UK Pounds
Share Price 2.13p
Change Today -0.13p
% Change -5.56 %
52 Week High 9.20p
52 Week Low 2.13p
Volume 0
Shares Issued 161.51m
Market Cap £3.43m

Trellus Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
47.08% above the market average47.08% above the market average47.08% above the market average47.08% above the market average47.08% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Price Trend
94.29% below the market average94.29% below the market average94.29% below the market average94.29% below the market average94.29% below the market average
78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average78.38% below the sector average
Income Not Available
Growth
23.83% below the market average23.83% below the market average23.83% below the market average23.83% below the market average23.83% below the market average
27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average27.78% below the sector average

Trellus Health Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Trellus Health Key Personnel

CEO Marla Dubinsky

Top of Page